Yongluan Lin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Yongluan Lin has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
Hailin Liang
Department of Cardiology, the First Affiliated Hospital of Shantou University Medical College, Shantou, China
2 shared publicationsJunhong Huang
Department of Cardiology, the First Affiliated Hospital of Shantou University Medical College, Shantou, China
2 shared publications- Bao-Jun Yang
Department of Cardiology, the First Affiliated Hospital of Shantou University Medical College, Shantou, China
1 shared publication Chujuan Zeng
Department of Cardiology, The First Affiliated Hospital of Shantou University Medical College of Shantou City, Shantou, China
1 shared publicationHaoxian Tang
Department of Cardiology, the First Affiliated Hospital of Shantou University Medical College, Shantou, China
1 shared publicationJiacai Lin
Department of Cardiology, The First Affiliated Hospital of Shantou University Medical College
1 shared publication
Latest Publications
- Open Access
- 8 July 2026
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 13, 1832873
The association between C-reactive protein-triglyceride glucose index and all-cause mortality in patients with cardiovascular-kidney-metabolic syndrome: a single-center retrospective cohort study
Background: Patients with cardiovascular-kidney-metabolic (CKM) syndrome have high mortality risk. The C-reactive protein–triglyceride glucose index (CTI) integrates inflammation and insulin resistance, yet its stage-specific prognostic value is undefined. Methods and results: This retrospective cohort study included 8,632 CKM patients (2020–2025), stratified by CTI quartiles. All-cause mortality was assessed using adjusted Cox models. Among 860 deaths (10.0%), CTI was an independent mortality predictor in both stage 0–3 (HR 1.68, 95% CI 1.30–2.18) and stage 4 CKM (HR 1.54, 1.33–1.77). Compared with Q1, Q4 patients had significantly higher risk (stage 0–3: HR 4.57, 2.32–8.99; stage 4: HR 2.26, 1.64–3.13). A linear dose-response relationship was confirmed ( P for nonlinear >0.05). CTI showed superior 1-year predictive performance over TyG index (AUC: stage 0–3, 0.73 vs. 0.62; stage 4, 0.69 vs. 0.51). Conclusion: CTI is a potent, independent predictor of all-cause mortality in CKM, with a linear dose-response relationship. By integrating inflammatory and metabolic pathways, it provides superior risk stratification over TyG index, highlighting its clinical utility.
- 8 July 2026
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 13, 1832873
Open AccessThe association between C-reactive protein-triglyceride glucose index and all-cause mortality in patients with cardiovascular-kidney-metabolic syndrome: a single-center retrospective cohort study
Background: Patients with cardiovascular-kidney-metabolic (CKM) syndrome have high mortality risk. The C-reactive protein–triglyceride glucose index (CTI) integrates inflammation and insulin resistance, yet its stage-specific prognostic value is undefined. Methods and results: This retrospective cohort study included 8,632 CKM patients (2020–2025), stratified by CTI quartiles. All-cause mortality was assessed using adjusted Cox models. Among 860 deaths (10.0%), CTI was an independent mortality predictor in both stage 0–3 (HR 1.68, 95% CI 1.30–2.18) and stage 4 CKM (HR 1.54, 1.33–1.77). Compared with Q1, Q4 patients had significantly higher risk (stage 0–3: HR 4.57, 2.32–8.99; stage 4: HR 2.26, 1.64–3.13). A linear dose-response relationship was confirmed ( P for nonlinear >0.05). CTI showed superior 1-year predictive performance over TyG index (AUC: stage 0–3, 0.73 vs. 0.62; stage 4, 0.69 vs. 0.51). Conclusion: CTI is a potent, independent predictor of all-cause mortality in CKM, with a linear dose-response relationship. By integrating inflammatory and metabolic pathways, it provides superior risk stratification over TyG index, highlighting its clinical utility.
- Open Access
- 16 December 2025
- Published by Springer Nature in BMC Cardiovascular Disorders
- Vol. 25 (1) , 867
Association between stress hyperglycemia ratio and all-cause mortality in patients with coronary heart disease
Stress hyperglycemia ratio (SHR) has been associated with adverse clinical outcomes in hospitalized patients with acute coronary syndromes (ACS). However,
- 16 December 2025
- Published by Springer Nature in BMC Cardiovascular Disorders
- Vol. 25 (1) , 867
Open AccessAssociation between stress hyperglycemia ratio and all-cause mortality in patients with coronary heart disease
Stress hyperglycemia ratio (SHR) has been associated with adverse clinical outcomes in hospitalized patients with acute coronary syndromes (ACS). However,